Stratos Wealth Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Sell |
3,201
-1,083
| -25% | -$482K | 0.02% | 589 |
|
|
2025
Q1 | $2.08M | Sell |
4,284
-1,097
| -20% | -$532K | 0.03% | 444 |
|
|
2024
Q4 | $2.17M | Sell |
5,381
-274
| -5% | -$110K | 0.03% | 453 |
|
|
2024
Q3 | $2.63M | Sell |
5,655
-62
| -1% | -$28.8K | 0.04% | 394 |
|
|
2024
Q2 | $2.68M | Buy |
5,717
+434
| +8% | +$203K | 0.04% | 375 |
|
|
2024
Q1 | $2.21M | Buy |
5,283
+2,157
| +69% | +$902K | 0.04% | 423 |
|
|
2023
Q4 | $1.27M | Buy |
3,126
+111
| +4% | +$45.2K | 0.02% | 538 |
|
|
2023
Q3 | $1.05M | Sell |
3,015
-344
| -10% | -$120K | 0.02% | 556 |
|
|
2023
Q2 | $1.18M | Buy |
3,359
+237
| +8% | +$83.4K | 0.03% | 487 |
|
|
2023
Q1 | $984K | Sell |
3,122
-838
| -21% | -$264K | 0.03% | 488 |
|
|
2022
Q4 | $1.14M | Buy |
3,960
+681
| +21% | +$197K | 0.03% | 476 |
|
|
2022
Q3 | $949K | Buy |
3,279
+205
| +7% | +$59.3K | 0.03% | 494 |
|
|
2022
Q2 | $866K | Buy |
3,074
+196
| +7% | +$55.2K | 0.02% | 553 |
|
|
2022
Q1 | $751K | Buy |
2,878
+228
| +9% | +$59.5K | 0.02% | 647 |
|
|
2021
Q4 | $582K | Sell |
2,650
-283
| -10% | -$62.2K | 0.01% | 756 |
|
|
2021
Q3 | $532K | Buy |
2,933
+543
| +23% | +$98.5K | 0.01% | 720 |
|
|
2021
Q2 | $482K | Sell |
2,390
-28
| -1% | -$5.65K | 0.01% | 783 |
|
|
2021
Q1 | $520K | Buy |
2,418
+946
| +64% | +$203K | 0.01% | 709 |
|
|
2020
Q4 | $348K | Buy |
1,472
+78
| +6% | +$18.4K | 0.01% | 795 |
|
|
2020
Q3 | $379K | Sell |
1,394
-641
| -31% | -$174K | 0.01% | 704 |
|
|
2020
Q2 | $591K | Buy |
2,035
+1,086
| +114% | +$315K | 0.02% | 538 |
|
|
2020
Q1 | $226K | Buy |
+949
| New | +$226K | 0.01% | 772 |
|
|
2018
Q4 | – | Sell |
-640
| Closed | -$123K | – | 2468 |
|
|
2018
Q3 | $123K | Buy |
+640
| New | +$123K | 0.01% | 1036 |
|
|
2018
Q2 | – | Sell |
-764
| Closed | -$125K | – | 2556 |
|
|
2018
Q1 | $125K | Sell |
764
-257
| -25% | -$42K | 0.01% | 1080 |
|
|
2017
Q4 | $153K | Buy |
+1,021
| New | +$153K | 0.01% | 984 |
|